Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Johansson, C.
Right arrow Articles by Wieslander, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johansson, C.
Right arrow Articles by Wieslander, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1993) 8: 1205-1210
© 1993 European Renal Association-European Dialysis and Transplant Association


research-article

Characterization of a non-Goodpasture autoantibody to type IV collagen

C. Johansson1,, R. Butkowski2, P. Swedenborg1, P. Alm3 and J. Wieslander4

1Department of Nephrology, University Hospital Lund, Sweden 2Department of Laboratory Medicine and Pathology, University of Minnesota Minnesota, Minneapolis, MN, USA 3Departrnent of Pathology, University Hospital Lund, Sweden 4Statens Serum Institut Copenhagen, Denmark

Correspondence and offprint requests to: Correspondence and offprint requests to: Charlott Johansson, Department of Nephrology, University Hospital, S-221 85 Lund, Sweden

Goodpasture's syndrome is a very severe and aggressive autoimmune kidney disease. The patients' autoantibodies, which are pathogenic, are restricted to the C-terminal region of the {alpha}3-chain of type IV collagen. In this paper we characterize an antitype IV collagen antibody from a patient with a nonprogressive form of glomerulonephntis.

ELISA and immunoblotting were used to study the specificity of this patient's antibodies. The patient had high titres of antibodies restricted to the C-terminal region of the {alpha}l-chain of type IV collagen. The antibody recognized an epitope hidden in the NC1 molecule which was fully exposed after denaturation or reduction. It was an IgG3 antibody composed of only lambda light chains, indicating that it has a potential to induce inflammatory damage and that it is probably monoclonal. This patient also had MPO-ANCA which were of IgGl subclass. Our patient had no disease progression during the 5 years of treatment.

Even though the anti-{alpha}1 (IV) antibodies react with the same domain, but of a different chain of type IV collagen compared to the Goodpasture's antibodies, they do not induce any severe damage. It is thus uncertain if the anti-{alpha}1 (IV) antibodies have any pathogenic role; the kidney damage might have been caused by the MPO-ANCA.

The findings support the theory that the anti-{alpha}3(IV) antibody causes disease in Goodpasture's syndrome and that antibodies restricted to other subunits of the C-terminal region of type IV collagen are less harmful.

Keywords: anti-GBM nephritis; anti-type IV collagen antibodies; type IV collagen; Goodpasture's syndrome; immunoblotting; ELISA


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. Yang, T. Hellmark, J. Zhao, Z. Cui, M. Segelmark, M.-h. Zhao, and H.-y. Wang
Antigen and Epitope Specificity of Anti-Glomerular Basement Membrane Antibodies in Patients with Goodpasture Disease with or without Anti-Neutrophil Cytoplasmic Antibodies
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1338 - 1343.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. A. Sinico, A. Radice, C. Corace, E. Sabadini, and B. Bollini
Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays
Nephrol. Dial. Transplant., February 1, 2006; 21(2): 397 - 401.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.